PL1890546T3 - Sposób poprawiania biodostępności kurkuminy - Google Patents

Sposób poprawiania biodostępności kurkuminy

Info

Publication number
PL1890546T3
PL1890546T3 PL05750098T PL05750098T PL1890546T3 PL 1890546 T3 PL1890546 T3 PL 1890546T3 PL 05750098 T PL05750098 T PL 05750098T PL 05750098 T PL05750098 T PL 05750098T PL 1890546 T3 PL1890546 T3 PL 1890546T3
Authority
PL
Poland
Prior art keywords
curcumin
bioavailability
improving
Prior art date
Application number
PL05750098T
Other languages
English (en)
Inventor
Benny Antony
Original Assignee
Benny Antony
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37481273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1890546(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Benny Antony filed Critical Benny Antony
Publication of PL1890546T3 publication Critical patent/PL1890546T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/40—Liliopsida [monocotyledons]
    • A01N65/48—Zingiberaceae [Ginger family], e.g. ginger or galangal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dentistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
PL05750098T 2005-05-30 2005-05-30 Sposób poprawiania biodostępności kurkuminy PL1890546T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05750098.5A EP1890546B1 (en) 2005-05-30 2005-05-30 Method for improving the bioavailability of curcumin
PCT/IN2005/000176 WO2006129323A1 (en) 2005-05-30 2005-05-30 A composition to enhance the bioavailability of curcumin

Publications (1)

Publication Number Publication Date
PL1890546T3 true PL1890546T3 (pl) 2019-04-30

Family

ID=37481273

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05750098T PL1890546T3 (pl) 2005-05-30 2005-05-30 Sposób poprawiania biodostępności kurkuminy

Country Status (9)

Country Link
US (7) US7736679B2 (pl)
EP (1) EP1890546B1 (pl)
JP (1) JP5039032B2 (pl)
DK (1) DK1890546T3 (pl)
ES (1) ES2709653T3 (pl)
HU (1) HUE042590T2 (pl)
PL (1) PL1890546T3 (pl)
PT (1) PT1890546T (pl)
WO (1) WO2006129323A1 (pl)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12053438B2 (en) * 2005-05-30 2024-08-06 Arjuna Natural Private Limited Formulation of curcuminoids with enhanced bioavailability of curcumin, demethoxycurcumin, bisdemethoxycurcumin and method of preparation and uses thereof
US8859020B2 (en) * 2005-05-30 2014-10-14 Benny Antony Treatment of alzheimer's with a curcuminoid mixture and essential oil of turmeric having 45% Ar-turmerone
US9492402B2 (en) * 2005-05-30 2016-11-15 Benny Antony Formulation of curcuminoids with enhanced bioavailability of curcumin, demethoxycurcumin, bisdemethoxycurcumin and method of preparation and uses thereof
WO2014068597A2 (en) * 2012-11-03 2014-05-08 Benny Antony Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
US20170042833A1 (en) * 2014-03-12 2017-02-16 Benny Antony Formulation of Curcuminoids with Enhanced Bioavailability of Curcumin, Demethoxycurcumin, Bisdemethoxycurcumin and method of preparation and uses thereof
PT1890546T (pt) * 2005-05-30 2019-01-23 Antony Benny Método para melhorar a biodisponibilidade da curcumina
US10286027B2 (en) * 2005-05-30 2019-05-14 Arjuna Natural Extracts, Ltd. Sustained release formulations of curcuminoids and method of preparation thereof
EP2315063A4 (en) * 2008-08-19 2011-08-17 Rohm Co Ltd Camera
US20120003177A1 (en) * 2008-09-17 2012-01-05 Youqing Shen Curcumin-containing polymers and water-soluble curcumin derivatives as prodrugs of prodrug carriers
US20100255133A1 (en) * 2009-04-07 2010-10-07 Shodoshima Healthy Land Co., Ltd. Extracted olive oil and production method thereof
WO2011082290A2 (en) * 2009-12-31 2011-07-07 Organomed Corporation Formulations from natural products, turmeric, and aspirin
US9393198B2 (en) * 2010-03-22 2016-07-19 Signpath Pharma Inc. Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
PL2555787T3 (pl) * 2010-04-05 2018-04-30 Benny Antony Formulacja kurkuminy o zwiększonej biodostępności kurkuminy i sposób jej wytwarzania i traktowania
WO2012023146A1 (en) * 2010-08-16 2012-02-23 Benny Antony A pharmaceutical composition of reformulated turmeric extract and a method thereof
US8785380B2 (en) 2011-02-01 2014-07-22 M/S Akay Flavours & Aromatics Pvt Ltd. Formulation containing curcuminoids exhibiting enhanced bioavailability
KR20150064234A (ko) 2011-05-16 2015-06-10 옴니액티브 헬스 테크놀로지스 리미티드 증가된 생체이용률을 갖는 커큐민을 포함하는 수용성 조성물 및 이의 방법
US12004868B2 (en) 2011-06-03 2024-06-11 Signpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
US10532045B2 (en) 2013-12-18 2020-01-14 Signpath Pharma, Inc. Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
US10117881B2 (en) 2011-06-03 2018-11-06 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
US8753674B2 (en) 2011-06-03 2014-06-17 Signpath Pharma Inc. Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
US10238602B2 (en) 2011-06-03 2019-03-26 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
US10349884B2 (en) 2011-06-03 2019-07-16 Sighpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
US10449193B2 (en) 2011-06-03 2019-10-22 Signpath Pharma Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
ITPD20120021A1 (it) 2012-01-26 2013-07-27 Fidia Farmaceutici "nuove composizioni farmaceutiche contenenti fosfatidilserina e curcumina".
JP5511895B2 (ja) * 2012-06-07 2014-06-04 アントニイ ベニー クルクミンの生物学的利用率を向上させるための組成物
HK1208907A1 (en) 2012-06-14 2016-03-18 Signpath Pharma Inc. Method and system for measuring the pharmacokinetics of liposomal curcumin and its metabolite tetrahydrocurcumin
US20140056828A1 (en) 2012-08-21 2014-02-27 Indiran Pather Novel formulations and uses for curcuma extracts
CA2882978A1 (en) 2012-08-31 2014-03-06 Signpath Pharma Inc. Curcumin-er, a liposomal-plga sustained release nanocurcumin for minimizing qt prolongation for cancer therapy
CN103450115A (zh) * 2013-04-19 2013-12-18 南京中医药大学 姜黄素衍生物及其作为大麻素受体调节剂的应用
US11338005B2 (en) 2013-06-28 2022-05-24 Arjuna Natural Private Limited Medicinal composition of amaranth origin for cardiovascular treatment
US20160151440A1 (en) * 2013-08-19 2016-06-02 Aurea Biolabs Private Limited A Novel Composition of Curcumin with Enhanced Bioavailability
CN103948874A (zh) * 2014-05-13 2014-07-30 陈文才 治疗肿瘤的中药及其应用方法
US10085951B2 (en) 2014-12-11 2018-10-02 Designs For Health, Inc. Curcuminoid formulations and related methods of treatment
CN104840904A (zh) * 2015-06-12 2015-08-19 李兰珍 一种治疗乳腺增生的中药组合物
US10336677B2 (en) 2016-03-25 2019-07-02 Biopteq Sprl Curcumin purification
AU2017257496B2 (en) 2016-04-27 2020-05-07 Signpath Pharma, Inc. Prevention of drug-induced atrio-ventricular block
US10076552B2 (en) 2016-08-09 2018-09-18 DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD. Multifunctional formulation comprised of natural ingredients and method of preparation/manufacturing thereof
WO2018185780A1 (en) * 2017-04-04 2018-10-11 Olene Life Sciences Private Limited Bioavailable composition for turmeric oleoresin
SG11202103782SA (en) * 2018-10-23 2021-05-28 Stabicon Life Sciences Pvt Ltd Formulation comprising water soluble particles of a non-curcuminoid and a curcuminoid
CN113727723A (zh) * 2018-11-03 2021-11-30 奥莱妮生命科学私人有限公司 制备草药提取物及其组合物的方法
AU2020291215A1 (en) * 2019-06-11 2021-12-23 Olene Life Sciences Private Limited Bioavailable turmeric composition and process for preparation thereof
JP2023515129A (ja) 2020-02-24 2023-04-12 クインシー バイオサイエンス，リミティド ライアビリティ カンパニー アポエクオリン及びクルクミン含有組成物及び方法
GB202011069D0 (en) 2020-07-17 2020-09-02 Univ Of Lincoln New curcumin products and uses
US20240358651A1 (en) 2021-04-01 2024-10-31 Snj Pharma Inc Oral nanoparticles for bioactive compound, and method of preparing same
US12251415B1 (en) * 2024-01-18 2025-03-18 Arjuna Natural Private Limited Curcuminoid composition of curcumin-keto, method of preparation and use thereof
WO2025153853A1 (en) * 2024-01-18 2025-07-24 Arjuna Natural Private Limited Curcuminoid composition of curcumin-keto, method of preparation and use thereof

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340250A (en) 1963-09-18 1967-09-05 Griffith Laboratories Extracting values from turmeric
US5120538A (en) 1990-02-05 1992-06-09 Pt Darya-Varia Laboratoria Combinations of compounds isolated from curcuma spp as anti-inflammatory agents
US6245350B1 (en) * 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
US5536506A (en) 1995-02-24 1996-07-16 Sabinsa Corporation Use of piperine to increase the bioavailability of nutritional compounds
US5861415A (en) * 1996-07-12 1999-01-19 Sami Chemicals & Extracts, Ltd. Bioprotectant composition, method of use and extraction process of curcuminoids
EP1045822B1 (en) * 1998-01-09 2003-05-07 Eurovita A/S Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
US6224871B1 (en) * 1998-03-11 2001-05-01 Reliv International, Inc. Dietary supplement for nutritionally promoting healthy joint function
JP2002528412A (ja) 1998-10-27 2002-09-03 イェール ユニバーシティ 分泌通路を通る不適当に折り畳まれたタンパク質のコンダクタンス
JP3496200B2 (ja) * 1999-02-12 2004-02-09 株式会社応微研 ウコンの苦味成分を減少させる方法及び苦味成分が減少されたウコン製品
BR0006024A (pt) 1999-04-08 2001-11-06 Metagenics Inc Composição para o tratamento de inflamação e dor em mamìferos
US6673843B2 (en) 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis
US6224877B1 (en) * 1999-09-16 2001-05-01 Council Of Scientific And Industrial Research Process for extraction of curcuminoids from curcuma species
US6576273B2 (en) 2000-08-24 2003-06-10 Chr. Hansen A/S Purification process for improving total yield of curcuminoid colouring agent
US6455078B1 (en) 2000-10-18 2002-09-24 Tzu-Sheng Wu Medicinal herbal composition for treating liver diseases and HIV
ATE410177T1 (de) 2001-02-09 2008-10-15 New Chapter Inc Zusammensetzung und verfahren zur rauchentgiftung
KR20020073847A (ko) * 2001-03-16 2002-09-28 주식회사 바이오시너젠 쿠르쿠민 또는 울금 추출물을 포함하는 치매 예방 및치료용 조성물
US6592896B2 (en) 2001-08-06 2003-07-15 The Quigley Corporation Medicinal composition and method of using it
US7037524B2 (en) 2001-10-03 2006-05-02 Herbalscience, Llc Oral delivery of a botanical
DE10157755A1 (de) * 2001-11-27 2003-06-12 Henkel Kgaa Wirkstoffhaltige Gelkapseln und ihre Verwendung
US6991814B2 (en) 2001-12-13 2006-01-31 Council Of Scientific And Industrial Research Herbal medicaments for the treatment of neurocerebrovascular disorders
WO2003049753A1 (en) 2001-12-13 2003-06-19 Council Of Scientific And Industrial Research Bioavailability enhancing activity of zingiber officinale linn and its extracts/fractions thereof
EP1453528B1 (en) * 2001-12-14 2009-07-22 Council of Scientific and Industrial Research Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders
KR20040089733A (ko) 2002-03-12 2004-10-21 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 쿠미눔 시미눔 및 이의 추출물 및 분획물의생체이용률/생체내효능 증진 활성
CN1306930C (zh) * 2003-05-05 2007-03-28 广州白云山医药科技发展有限公司 抗病毒软胶囊及其制备方法
JP2004331539A (ja) * 2003-05-06 2004-11-25 Maruzen Pharmaceut Co Ltd 肝臓疾患予防治療剤及び肝臓疾患予防治療用飲食物
CN1302769C (zh) 2003-08-08 2007-03-07 李德山 姜黄油提取物注射水剂及其制备方法和用途
CN1489994A (zh) 2003-08-22 2004-04-21 南京康海医药开发有限公司 姜黄脂溶性苯丙乙烯类成分提取物及其制剂新用途
US20050049299A1 (en) 2003-08-26 2005-03-03 Aggarwal Bharat B. Selective inhibitors of stat-3 activation and uses thereof
CN1319524C (zh) 2003-08-27 2007-06-06 谢恬 姜黄油提取物滴丸及其制备方法和用途
US7205011B2 (en) * 2003-11-14 2007-04-17 Board Of Regents, Acting For And On Behalf Of, University Of Arizona Anti-inflammatory activity of a specific turmeric extract
US7067159B2 (en) 2003-12-05 2006-06-27 New Chapter, Inc. Methods for treating prostate cancer with herbal compositions
US7070816B2 (en) 2003-12-05 2006-07-04 New Chapter, Inc. Methods for treating prostatic intraepithelial neoplasia with herbal compositions
PT1890546T (pt) * 2005-05-30 2019-01-23 Antony Benny Método para melhorar a biodisponibilidade da curcumina
US20170202785A1 (en) * 2005-05-30 2017-07-20 Benny Antony Formulation of Curcumin with Enhanced Bioavailability of Curcumin and method of preparation and treatment thereof
US8859020B2 (en) * 2005-05-30 2014-10-14 Benny Antony Treatment of alzheimer's with a curcuminoid mixture and essential oil of turmeric having 45% Ar-turmerone
US10543277B2 (en) * 2005-05-30 2020-01-28 Arjuna Natural Private Limited Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
US20170042833A1 (en) * 2014-03-12 2017-02-16 Benny Antony Formulation of Curcuminoids with Enhanced Bioavailability of Curcumin, Demethoxycurcumin, Bisdemethoxycurcumin and method of preparation and uses thereof
US7883728B2 (en) * 2005-05-30 2011-02-08 Arjuna Natural Extracts, Ltd. Composition to enhance the bioavailability of curcumin
US10286027B2 (en) * 2005-05-30 2019-05-14 Arjuna Natural Extracts, Ltd. Sustained release formulations of curcuminoids and method of preparation thereof

Also Published As

Publication number Publication date
US20170360869A1 (en) 2017-12-21
US10485843B2 (en) 2019-11-26
JP2008545740A (ja) 2008-12-18
US7736679B2 (en) 2010-06-15
EP1890546A4 (en) 2010-01-13
US20110092603A1 (en) 2011-04-21
ES2709653T3 (es) 2019-04-17
WO2006129323A1 (en) 2006-12-07
HUE042590T2 (hu) 2019-07-29
US20140093594A1 (en) 2014-04-03
US8895087B2 (en) 2014-11-25
JP5039032B2 (ja) 2012-10-03
US20150037442A1 (en) 2015-02-05
US9861677B2 (en) 2018-01-09
US8153172B2 (en) 2012-04-10
EP1890546A1 (en) 2008-02-27
US7879373B2 (en) 2011-02-01
DK1890546T3 (en) 2019-03-11
US8623431B2 (en) 2014-01-07
US20070148263A1 (en) 2007-06-28
US20100217045A1 (en) 2010-08-26
EP1890546B1 (en) 2018-11-28
US20120220666A1 (en) 2012-08-30
PT1890546T (pt) 2019-01-23

Similar Documents

Publication Publication Date Title
PT1890546T (pt) Método para melhorar a biodisponibilidade da curcumina
ZA200705425B (en) Method for the manufacture of hydrocarbons
IL188330A0 (en) Processes for the preparation of
IL181303A0 (en) Method for the production of dihydropteridinones
ZA200804264B (en) Process for the preparation of ferri-succinylcasein
IL213474A0 (en) Processes for the preparation of cyclopropyl-amide derivatives
ZA200600495B (en) Method of treatment for improved bioavailability
ZA200704189B (en) Method for the manufacture of extended steel products
EG24870A (en) Method for deodorisation
ZA200601910B (en) Process for the preparation of organosilances
IL190139A0 (en) Method for the determination of poloxamers
EP1964538A4 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL SUBSTANCES
PL1962960T3 (pl) Sposób mikronizowania
SI1937662T1 (sl) Postopek priprave duloksetina
GB0506349D0 (en) Forming method
PL377704A1 (pl) Sposób wytwarzania naturalnego preparatu
PL378004A1 (pl) Sposób wytwarzania R-pantolaktonu
PL378375A1 (pl) Sposób wytwarzania nanoceramik BaTiO₃
PL373928A1 (pl) Sposób wytwarzania imatinibu
PL377182A1 (pl) Sposób wytwarzania sera niedojrzewającego
PL373688A1 (pl) Sposób wytwarzania 7-hydroksyflawonu
PL377916A1 (pl) Sposób wytwarzania optycznie czystego R-(–)-1-okten-3-olu
PL373925A1 (pl) Sposób wytwarzania kwasów ureidoalkilofosfonowych
PL375688A1 (pl) Sposób wytwarzania emulsji
PL372059A1 (pl) Sposób wytwarzania emulsji